The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Open accessAbstract
genes and the role of BRCA mutations in tumor initiation, regulation of cancer stemness, therapy resistance and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
BRCA mutations in the manifestation and treatment of ovarian cancer
Pan, Z., & Xie, X. (2017) · Oncotarget · doi:10.18632/oncotarget.18280 · Cited by 64
Podszywalow‐Bartnicka, P., Wołczyk, M., Kusio-Kobiałka, M., Wolanin, K., Skowronek, K., Nieborowska-Skorska, M., Dasgupta, Y., Skórski, T., & Piwocka, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.965013 · Cited by 63
Brca1 regulates in vitro differentiation of mammary epithelial cells
Kubista, M., Rosner, M., Kubista, E., BERNASCHEK, G., & Hengstschläger, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205580 · Cited by 62
Ho, C., Chang, S.-F., Hsiao, C.-C., Chien, T.-Y., & Shih, D. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-23 · Cited by 58
BRCA1 Ubiquitinates RPB8 in Response to DNA Damage
Wu, W., Nishikawa, H., Hayami, R., Sato, K., Honda, A., Aratani, S., Nakajima, T., Fukuda, M., & Ohta, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3187 · Cited by 57
BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
Kan, C. E., & Zhang, J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.05.037 · Cited by 56
Yi, Y., Kang, H., & Bae, I. (2014) · Cancers · doi:10.3390/cancers6020771 · Cited by 55
Cao, L., Xu, X., Cao, L. L., Wang, R., Coumoul, X., Kim, S. S., & Deng, C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm060 · Cited by 54
BRCA1 Regulates IFN-γ Signaling through a Mechanism Involving the Type I IFNs
Buckley, N. E., Hosey, A. M., Gorski, J. J., Purcell, J. W., Mulligan, J. M., Harkin, D. P., & Mullan, P. B. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0250 · Cited by 53
Buckley, N. E., tSaoir, C. N. A., Blayney, J. K., Oram, L. C., Crawford, N., D’Costa, Z., Quinn, J. E., Kennedy, R. D., Harkin, D. P., & Mullan, P. B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt626 · Cited by 53
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice
Vasanthakumar, A., Arnovitz, S., Marquez, R., Lepore, J. B., Rafidi, G., Asom, A. S., Weatherly, M., Davis, E. M., Neistadt, B., Duszynski, R. J., et al. (2015) · Blood · doi:10.1182/blood-2015-03-635599 · Cited by 53
Yi, Y. W., Kang, H. J., Kim, H. J., Hwang, J. S., Wang, A., & Bae, I. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21905 · Cited by 52
Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations
Laitman, Y., Feng, B., Zamir, I. N., Weitzel, J. N., Duncan, P. R., Port, D., Thirthagiri, E., Teo, S., Evans, D. G., Latif, A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.124 · Cited by 50
A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase
Horwitz, A. A., Affar, E. B., Heine, G. F., Shi, Y., & Parvin, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610481104 · Cited by 50
AKT regulates BRCA1 stability in response to hormone signaling
Nelson, A., Lyons, T. R., Young, C. D., Hansen, K. C., Anderson, S. M., & Holt, J. T. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.019 · Cited by 48
Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation
Kim, S., Jin, H. K., Seo, H. R., Lee, H. J., & Lee, Y. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0153-0 · Cited by 47
Dizin, É., & Irminger‐Finger, I. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.025 · Cited by 45
Moro, L., Arbini, A., Yao, J. L., di Sant'Agnese, P. A., Marra, E., & Greco, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00719.x · Cited by 45
Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis
Huang, Y. (2018) · Medicine · doi:10.1097/md.0000000000009380 · Cited by 44
Mutations in BRCA2 and taxane resistance in prostate cancer
Nientiedt, C., Heller, M., Endris, V., Volckmar, A., Zschäbitz, S., Tapia-Laliena, M. Á., Duensing, A. U., Jäger, D., Schirmacher, P., Sültmann, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04897-x · Cited by 43
Brca2 and Trp53 Deficiency Cooperate in the Progression of Mouse Prostate Tumourigenesis
Francis, J. C., McCarthy, A., Thomsen, M. K., Ashworth, A., & Swain, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000995 · Cited by 42
Nelson, A., & Holt, J. T. (2010) · Radiation Research · doi:10.1667/rr1290.1 · Cited by 40
Substrates of the BRCA1-dependent ubiquitin ligase
Starita, L. M., & Parvin, J. D. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.2.2479 · Cited by 40
(2004) · The Women s Oncology Review · doi:10.3109/14733400400013030 · Cited by 40
The Clinical Significance of Unknown Sequence Variants in BRCA Genes
Calò, V., Bruno, L., Paglia, L. L., Pérez, M., Margarese, N., Gaudio, F. D., & Russo, A. D. (2010) · Cancers · doi:10.3390/cancers2031644 · Cited by 38
BRCA1 and p53 regulate critical prostate cancer pathways
Luca, P. D., Moiola, C., Zalazar, F., Gardner, K., Vazquez, E., & Siervi, A. D. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.12 · Cited by 36
Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function
Mgbemena, V. E., Signer, R. A. J., Wijayatunge, R., Laxson, T., Morrison, S. J., & Ross, T. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.075 · Cited by 36
BRCA2 and homologous recombination
Orelli, B. J., & Bishop, D. K. (2001) · Breast Cancer Research · doi:10.1186/bcr310 · Cited by 34
Bernier, J., & Poortmans, P. M. (2014) · The Breast · doi:10.1016/j.breast.2014.12.003 · Cited by 34
A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
Li, D., Bi, F., Chen, N.-N., Cao, J.-M., Sun, W., Zhou, Y., Li, C., & Yang, Q. F. (2014) · Scientific Reports · doi:10.1038/srep06666 · Cited by 33
BRCA2 and Smad3 synergize in regulation of gene transcription
Preobrazhenska, O., Yakymovych, M., Kanamoto, T., Yakymovych, I., Stoika, R. S., Heldin, C., & Souchelnytskyi, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205732 · Cited by 33
CLINICAL AND PATHOLOGICAL FEATURES OF OVARIAN CANCER IN WOMEN WITH GERM-LINE MUTATIONS OF BRCA1
Ubin, C. R., Enjamin, I. V. B., Ehbakht, K. I. B., Iroyuki, H., Akahashi, T., Organ, M. A. A. M., Olsi, A. L. I. V., Ndrew, A., Erchuck, B., Uto, M., et al. (1996) · Cited by 33
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
van Voss, M. R. H., van der Groep, P., Bart, J., van der Wall, E., & van Diest, P. J. (2011) · Cellular Oncology · doi:10.1007/s13402-010-0007-3 · Cited by 31
Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer
Jiang, T., Shi, W., Natowicz, R., Ononye, S. N., Wali, V. B., Kluger, Y., Pusztai, L., & Hatzis, C. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-876 · Cited by 30
Deciphering intratumor heterogeneity using cancer genome analysis
Ryu, D., Joung, J., Kim, N. K. D., Kim, K., & Park, W. (2016) · Human Genetics · doi:10.1007/s00439-016-1670-x · Cited by 28
BRCA1 can stimulate gene transcription by a unique mechanism
Nadeau, G., Boufaied, N., Moisan, A., Lemieux, K. M., Cayanan, C. S., Monteiro, Á. N. A., & Gaudreau, L. R. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd059 · Cited by 27
BRCA1 shields vascular smooth muscle cells from oxidative stress
Lovren, F., Pan, Y., Quan, A., Singh, K. K., Khan, R., Gupta, N., Brezden‐Masley, C., Teoh, H., Wheatcroft, M., Al-Omran, M. A., et al. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.060 · Cited by 27
The role of BRCA1 and BRCA2 in prostate cancer
Jensen, R. A. (2013) · Frontiers in bioscience · doi:10.2741/4191 · Cited by 27
Li, D., Bi, F., Chen, N., Cao, J.-M., Sun, W., Zhou, Y., Cao, C., Li, C., & Yang, Q. F. (2014) · Oncotarget · doi:10.18632/oncotarget.1800 · Cited by 25
Tang, M. K. S., Kwong, A., Tam, K., Cheung, A., Ngan, H., Xia, W., & Wong, A. S. T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.026 · Cited by 25
miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
Tommasi, S., Pinto, R., Danza, K., Pilato, B., Palumbo, O., Micale, L., & Summa, S. D. (2016) · Oncotarget · doi:10.18632/oncotarget.10345 · Cited by 25
Zhu, Y., Zhai, K., Ke, J., Li, J., Gong, Y., Yang, Y., Tian, J., Zhang, Y., Zou, D., Peng, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16422 · Cited by 24
Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b
Mogilyansky, E., Clark, P., Quann, K., Zhou, H., Londin, E. R., Yi, J., & Rigoutsos, I. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00143 · Cited by 23
Chromatin remodeling, BRCA1, SAHF and cellular senescence
Tu, Z., Aird, K. M., & Zhang, R. (2013) · Cell Cycle · doi:10.4161/cc.24986 · Cited by 21
Foulkes, W. D., Metcalfe, K., Sun, P., Hanna, W. M., Lynch, H. T., Ghadirian, P., Tung, N., Olopade, O. I., Weber, B. L., McLennan, J., et al. (2004) · TSpace (University of Toronto) · Cited by 19
Cassidy, L. D., Liau, S., & Venkitaraman, A. R. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.005 · Cited by 16
Wang, S., Li, Y., Hsu, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476556 · Cited by 15
Okada, S., Tokunaga, E., Kitao, H., Akiyoshi, S., Yamashita, N., Saeki, H., Oki, E., Morita, M., Kakeji, Y., & Maehara, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2166-5 · Cited by 15
Rocca, C. J., Soares, D. G., Bouzid, H., Henriques, J. A. P., Larsen, A. K., & Escargueil, A. E. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1042632 · Cited by 14
Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers
van Voss, M. R. H., van der Groep, P., Bart, J., van der Wall, E., & van Diest, P. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1005-x · Cited by 14
Tissue-specific tumor suppression by BRCA1
Lee, E. Y.-H. P., & Abbondante, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403033111 · Cited by 14
The role of Rak in the regulation of stability and function of BRCA1
Kim, J., Ha, G., Campo, L., Denning, M. F., Patel, T. B., Osipo, C., Lin, S., & Breuer, E.-K. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5717 · Cited by 11
EZH2 takes the stage when BRCA1 loses
Wang, L., & Huang, H. (2013) · Cell Cycle · doi:10.4161/cc.26785 · Cited by 10
Stefánsson, Ó. A., & Esteller, M. (2012) · Breast Cancer Research · doi:10.1186/bcr3119 · Cited by 9
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication
Tarsounas, M., & Sung, P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0218-z · Cited by 359
Piombino, C., Pipitone, S., Tonni, E., Mastrodomenico, L., Oltrecolli, M., Tchawa, C., Matranga, R., Roccabruna, S., D’Agostino, E., Pirola, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094624 · Cited by 15
Metadata
- Authors
- Gorodetska, I., Kozeretska, I., & Dubrovska, A.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2019
- Volume
- 10
- Issue
- 9
- Pages
- 2109-2127
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W2947754660
- Cited by
- 269
- References
- 254
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.